Daxxify Reviews 2026: 6-Month Longevity in the Real World

Medically reviewed by the OC Weight Loss and Medspa clinical team. Last updated May 14, 2026.

What Daxxify actually is

Daxxify is a botulinum toxin type A injectable made by Revance Therapeutics. It received FDA approval in September 2022 for the temporary improvement of moderate to severe glabellar lines (the “11s” between the eyebrows) in adults, and later approval for cervical dystonia. What makes Daxxify different is the carrier — instead of human serum albumin, it uses a proprietary peptide excipient called RTP004 to stabilize the toxin molecule. That formulation change is the basis for its longer-duration claim.

If you want context on how Daxxify sits within the broader category, our neurotoxins guide compares all four FDA-approved type-A products: Botox, Dysport, Xeomin, and Daxxify.

What the SAKURA trials actually showed

Revance ran two pivotal Phase 3 trials — SAKURA 1 and SAKURA 2 — plus an open-label long-term study called SAKURA 3. The trials enrolled adults with moderate-to-severe glabellar lines and randomized them to Daxxify or placebo at a single 40-unit dose.

Key reported findings, summarized at a high level:

• The median time to loss of effect was approximately 24 weeks (roughly 6 months)
• A subset of patients maintained at least a 1-point improvement on the validated frown-line scale at 27–36 weeks
• Onset of effect was reported in many patients within 1–2 days — not dramatically different from Botox
• The safety profile across thousands of patient-treatments was consistent with the broader botulinum-toxin class

Read the FDA-approved label directly via the FDA Drugs@FDA listing for the official efficacy and safety summary — trial numbers in marketing materials and trial publications can differ slightly depending on the endpoint chosen.

How long does Daxxify actually last in real practice?

Trial averages and individual results are not the same thing. After several years of post-approval use, a rough pattern has emerged in clinic. Among patients we treat for glabellar lines with a standard 40-unit dose, the response usually splits into three groups:

The patients most likely to fall in the third group share a few features: very expressive musculature, high baseline metabolic rate, regular intense cardio training, and a history of fast Botox metabolism. The patients most likely to land in the 6-month group tend to have moderate (not extreme) muscle activity and less aggressive expression patterns.

How does Daxxify compare to Botox?

Daxxify units and Botox units are not interchangeable. A 40-unit Daxxify glabellar dose is the labeled equivalent of a 20-unit Botox dose. Pricing per unit therefore is not the right comparison — total cost per treatment is. For a head-to-head clinical comparison, see our post on Botox vs Daxxify.

What patients commonly report

From the post-treatment feedback we collect:

• Onset feels similar to Botox. Most patients see the effect take hold by day 3–5.
• Strength of effect feels similar. A frown is a frown — well-dosed glabellar Daxxify and well-dosed glabellar Botox produce visually equivalent freezing.
• The longevity is the headline. Patients who hit 5–6 months are vocal about it. Patients who hit 4 say it was still longer than their Botox.
• The premium price is the friction. Sticker shock at the first visit is real, especially compared to a familiar Botox quote.
• Side-effect profile is unremarkable. Most reports are headache, mild bruising, or transient brow heaviness — same as any neurotoxin.

Who Daxxify is actually right for

Good fit:

• Patients who dislike scheduling and want to come in 2 times per year instead of 3–4
• Travelers who plan around events months out and want predictable longevity
• Patients who have built a long Botox relationship and are curious whether they can stretch the interval without losing effect
• Patients with documented fast Botox metabolism who consistently return at 8–10 weeks

Less ideal fit:

• First-time Botox patients — the higher commitment and higher price point on day one is steep when you have not yet established how you respond to neurotoxin
• Patients who want to micro-adjust dosing every visit — if a tweak is needed, you live with it longer
• Patients on a tight budget; the per-visit cost is meaningfully higher
• Patients who want very subtle, expressive results — you can absolutely do baby Botox style dosing with Daxxify, but it tends to defeat the longevity claim

Cost, value, and how to think about the premium

A clean way to evaluate value: compare total annual spend, not per-visit price.

• Botox glabellar at $350/visit × 4 visits = $1,400/year
• Daxxify glabellar at $750/visit × 2 visits = $1,500/year

Annual cost is close. The differentiator is not money — it is the number of visits and the lifestyle of the patient. For the full Orange County pricing breakdown across products, see our Botox cost in Orange County page.

Side effects and what to watch for

Daxxify carries the standard botulinum-toxin class warnings:

• Headache, eyelid ptosis (drooping), brow heaviness, injection-site bruising
• Asymmetric response — addressed with a 2-week touch-up
• Rare allergic reaction
• Class boxed warning regarding distant spread of toxin effect — clinically meaningful events at cosmetic doses are exceedingly rare

Because Daxxify lasts longer, an undesired result (heavy brow, asymmetric arch) also lasts longer. That is the single most important counseling point at the consult. Conservative first-time dosing is the right approach.

What happens if you mix or switch products

Some patients alternate between Daxxify in colder months (fewer events, longer interval okay) and Botox in summer (more weddings and events, micro-adjustments preferred). Others use Daxxify on the glabella, where movement is rarely needed, and Botox on the forehead, where preserved expression matters. There is no medical reason these cannot coexist; they should not be injected in the same point in the same session, but using both at different areas in the same visit is common practice.

Patients who have produced antibodies to one neurotoxin (rare) sometimes switch products entirely. Xeomin, with no complexing proteins, is the usual fallback in those cases — see our Botox vs Xeomin post for that scenario in detail.

What we tell first-time Daxxify patients at consult

• Plan for 5 months as your working assumption, not 6. If you get more, treat it as a bonus.
• Take photos at baseline, week 2, week 8, month 4, and month 5. The data tells you whether you are a long-duration responder.
• Do not chase the “6 month” goal at the cost of over-treating. A heavy brow that lasts five months is a bad deal.
• If you are a fast Botox metabolizer, the upgrade is meaningful but unlikely to be 2x. Expect maybe 4–5 months instead of 2.5–3.
• The cost-per-month math is what to evaluate, not the sticker price per visit.

Common myths about Daxxify

• “It works in 24 hours.” Some patients see early activity at day 1–2, but full effect is still around days 7–14, similar to Botox.
• “It is twice as strong as Botox.” Units are not comparable. The treatment effect is comparable; the duration is what differs.
• “Everyone gets 6 months.” Trial median is about 6 months. Your individual result depends on metabolism, muscle activity, and dose accuracy.
• “You cannot get a touch-up.” You can. A small 2-week balancing dose is standard practice.

Frequently asked questions

Talk to a clinician at OC Weight Loss and Medspa

If you are tired of returning every 3 months and want to test a longer-duration neurotoxin, Daxxify is worth a careful conversation. We will assess your muscle activity, your prior neurotoxin history, and your goals — then we will be honest about whether you are a likely 6-month responder or whether you may land in the 4-month group. Explore the full neurotoxins guide or our local Botox in Mission Viejo page.

Book a free consultation